Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Solvay Pharmaceuticals |
---|---|
Information provided by: | Solvay Pharmaceuticals |
ClinicalTrials.gov Identifier: | NCT00543647 |
The purpose of this study was to test the effect of fenofibrate treatment on glomerular filtration rate (GFR), kidney hemodynamics and tubular function in middle-aged subjects with normal kidney function to further investigate the increase in creatinine levels observed in fenofibrate-treated subjects.
Condition | Intervention | Phase |
---|---|---|
Healthy Volunteers |
Drug: Fenofibrate 160 mg tablet Drug: Placebo |
Phase I |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double Blind (Subject, Investigator), Placebo Control, Crossover Assignment, Efficacy Study |
Official Title: | A Double-Blind, Cross-Over, Placebo-Controlled Study Evaluating the Effect of Fenofibrate 160 mg Tablets on Glomerular Filtration Rate and Other Renal Function Test in Healthy Subjects |
Enrollment: | 24 |
Study Start Date: | August 2002 |
Study Completion Date: | March 2003 |
Arms | Assigned Interventions |
---|---|
1: Experimental | Drug: Fenofibrate 160 mg tablet |
2: Placebo Comparator | Drug: Placebo |
Ages Eligible for Study: | 30 Years to 60 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
Study ID Numbers: | CFEN 0201 |
Study First Received: | October 12, 2007 |
Last Updated: | October 12, 2007 |
ClinicalTrials.gov Identifier: | NCT00543647 |
Health Authority: | United Kingdom: Medicines and Healthcare Products Regulatory Agency |
Fenofibrate Glomerular filtration rate inulin clearance |
creatinine healthy volunteers cross-over |
Healthy Procetofen |
Antimetabolites Molecular Mechanisms of Pharmacological Action Therapeutic Uses Antilipemic Agents Pharmacologic Actions |